BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37129315)

  • 41. Transoral robotic retropharyngeal node dissection in oropharyngeal squamous cell carcinoma: Patterns of metastasis and functional outcomes.
    Troob S; Givi B; Hodgson M; Mowery A; Gross ND; Andersen PE; Clayburgh D
    Head Neck; 2017 Oct; 39(10):1969-1975. PubMed ID: 28758272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluating the impact of smoking on disease-specific survival outcomes in patients with human papillomavirus-associated oropharyngeal cancer treated with transoral robotic surgery.
    Roden DF; Hobelmann K; Vimawala S; Richa T; Fundakowski CE; Goldman R; Luginbuhl A; Curry JM; Cognetti DM
    Cancer; 2020 Jan; 126(9):1873-1887. PubMed ID: 32032441
    [TBL] [Abstract][Full Text] [Related]  

  • 43. De-intensified adjuvant (chemo)radiotherapy versus standard adjuvant chemoradiotherapy post transoral minimally invasive surgery for resectable HPV-positive oropharyngeal carcinoma.
    Howard J; Dwivedi RC; Masterson L; Kothari P; Quon H; Holsinger FC
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012939. PubMed ID: 30550641
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical salvage of human papillomavirus-positive oropharyngeal cancer: Secondary analysis of a randomized controlled trial.
    Quan DL; Grauer JS; Sunkara PR; Cramer JD
    Cancer; 2023 Feb; 129(3):376-384. PubMed ID: 36401615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Application of transoral robotic surgery in treatment of oropharyngeal squamous cell carcinoma].
    Zhang X; Chen SW; Yang ZY; Chen JT; Su X; Yang AK; Song M
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 May; 57(5):545-551. PubMed ID: 35610671
    [No Abstract]   [Full Text] [Related]  

  • 48. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Swallowing and communication outcomes following primary transoral robotic surgery for advanced or recurrent oropharyngeal cancer: Case series.
    Charters E; Bogaardt H; Freeman-Sanderson A; Ballard K; Davies S; Oates J; Clark J
    Int J Speech Lang Pathol; 2022 Aug; 24(4):407-416. PubMed ID: 34547959
    [No Abstract]   [Full Text] [Related]  

  • 50. HPV/p16-positive oropharyngeal cancer treated with transoral robotic surgery: The roles of margins, extra-nodal extension and adjuvant treatment.
    Nichols DS; Zhao J; Boyce BJ; Amdur R; Mendenhall WM; Danan D; Hitchcock K; Ning K; Keyes K; Lee JH; Dziegielewski PT
    Am J Otolaryngol; 2021; 42(1):102793. PubMed ID: 33130532
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Swallowing outcomes for patients with oropharyngeal squamous cell carcinoma treated with primary (chemo)radiation therapy receiving either prophylactic gastrostomy or reactive nasogastric tube: A prospective cohort study.
    Goff D; Coward S; Fitzgerald A; Paleri V; Moor JW; Patterson JM
    Clin Otolaryngol; 2017 Dec; 42(6):1135-1140. PubMed ID: 28128886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Chillakuru Y; Benito DA; Strum D; Mehta V; Saini P; Shim T; Darwish C; Joshi AS; Thakkar P; Goodman JF
    Head Neck; 2021 Jul; 43(7):2259-2273. PubMed ID: 33899949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nasogastric tube feeding after transoral robotic surgery for oropharynx carcinoma.
    Plonowska KA; Ochoa E; Zebolsky AL; Patel N; Hoppe KR; Ha PK; Heaton CM; Ryan WR
    Am J Otolaryngol; 2021; 42(3):102857. PubMed ID: 33513477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Holcomb AJ; Herberg M; Strohl M; Ochoa E; Feng AL; Abt NB; Mokhtari TE; Suresh K; McHugh CI; Parikh AS; Sadow P; Faquin W; Faden D; Deschler DG; Varvares MA; Lin DT; Fakhry C; Ryan WR; Richmon JD
    Head Neck; 2021 Aug; 43(8):2434-2444. PubMed ID: 33856083
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transoral robotic surgery alone for oropharyngeal cancer: quality-of-life outcomes.
    Choby GW; Kim J; Ling DC; Abberbock S; Mandal R; Kim S; Ferris RL; Duvvuri U
    JAMA Otolaryngol Head Neck Surg; 2015 Jun; 141(6):499-504. PubMed ID: 25834991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review.
    Dowthwaite S; Jackson J; Dzienis M; Khoo E; Cronin M; Guazzo E
    Curr Oncol Rep; 2023 May; 25(5):501-510. PubMed ID: 36881215
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Ottenstein L; Cornett H; Switchenko JM; Nathan M; Thomas S; Gillespie AI; McColloch N; Barrett T; Studer MB; Brinkman M; Kaka AS; Boyce BJ; Ferris RL; Aiken AH; El-Deiry M; Beitler JJ; Patel MR
    Head Neck; 2021 May; 43(5):1629-1640. PubMed ID: 33547716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal Analysis of Swallowing Displacement Kinematics After Oropharyngeal Cancer Treatment.
    Kidane J; Laus J; Gulati A; Gochman GE; Schneider SL; Chan JW; Yom SS; Ha P; Boscardin WJ; Ryan WR; Ma Y
    Laryngoscope; 2023 Jun; 133(6):1339-1348. PubMed ID: 36054296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer.
    Gilja S; Kumar A; Kapustin D; Su V; Rubin SJ; Chai R; Roof SA; Khan MN
    Laryngoscope; 2024 Apr; 134(4):1733-1740. PubMed ID: 37933810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.